Clinical Trial Update: Ferumoxytol-enhanced Brain MRI in HIV-associated Neurocognitive Disorders [Phase 1]

View source ↗

Summary

Phase 1 study evaluating ferumoxytol-enhanced MRI for HIV-associated neurocognitive disorder has been completed, sponsored by the University of Hawaii.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hiv-associated Neurocognitive Disorder

Drugs mentioned

• Ferumoxytol (Feraheme) (ferumoxytol)

Snippet

Sponsor: University of Hawaii | Conditions: HIV Dementia | Phase 1 | Status: COMPLETED